Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Inhalation-type pharmaceutical composition for the treatment of lung cancer and preparation method thereof

An inhalation and composition technology, which is applied in the field of inhalation pharmaceutical composition and its preparation, can solve the problems that the medicine is not suitable for long-term use, severe vomiting of patients, etc., and achieve the effect of increasing the curative effect of medicine absorption

Inactive Publication Date: 2015-11-04
林信涌
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the above-mentioned drugs usually have some side effects, such as severe vomiting and other adverse side effects in patients after taking cisplatin (Cisplatin), which makes these drugs unsuitable for long-term use

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Inhalation-type pharmaceutical composition for the treatment of lung cancer and preparation method thereof
  • Inhalation-type pharmaceutical composition for the treatment of lung cancer and preparation method thereof
  • Inhalation-type pharmaceutical composition for the treatment of lung cancer and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0025] In order to make the advantages, spirit and characteristics of the present invention more easily and clearly understood, the following will be described and discussed in detail with reference to the accompanying drawings. It should be noted that these embodiments are only representative embodiments of the present invention, and the specific methods, devices, conditions, materials, etc. exemplified therein are not intended to limit the present invention or the corresponding embodiments.

[0026] The invention proposes an inhalation pharmaceutical composition for treating lung cancer, which includes a first gas and atomized medicinal liquid. The first gas contains hydrogen, and the concentration of hydrogen in gas volume of the inhalation pharmaceutical composition is between 2% and 6%. The nebulized drug solution contains one selected from the group consisting of Cisplatin, Docetaxel, Etoposide, Gefitinib and Erlotinib or its combination.

[0027] In an embodiment of t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides an inhalation-type pharmaceutical composition for lung cancer and preparation method thereof, comprising a first gas and an atomized medicine. The first gas comprises hydrogen. The gas volume concentration of hydrogen in the inhalation-type pharmaceutical composition is between 2 to 96%. The atomized medicine is selected from a group comprising cisplatin, docetaxel, etoposide, gefitinib, erlotinib, and any combination thereof. The inhalation-type pharmaceutical composition of the present invention can remove harmful radicals in the body of the patient through the use of hydrogen while also increases the absorption effect of the medicine for the patient by using an atomized medicine. At the same time, because the use of the small amount of the vaporized pharmaceutical liquid can indirectly reduce the side effects on the user.

Description

technical field [0001] The invention relates to an inhalation pharmaceutical composition and a preparation method thereof, in particular to an inhalation pharmaceutical composition for treating lung cancer and a preparation method thereof. Background technique [0002] Lung cancer is a disease caused by the uncontrolled growth of cells in the lung tissue. Such cell growth can cause metastasis, that is, invasion of adjacent tissues and penetration into tissues outside the lung. Most primary lung cancers are malignant epithelial cell tumors of the lung, which result from lesions of epithelial cells. In addition, according to statistics in 2004, lung cancer is one of the leading causes of cancer-related deaths in both men and women, and about 1.3 million people worldwide die from lung cancer every year. [0003] According to statistics, the 5-year survival rate of lung cancer patients remains at 17%, with little improvement for decades. In fact, early diagnosis of lung cance...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K33/24A61K33/00A61K9/72A61P11/00A61P35/00A61K31/337A61K31/7048A61K31/5377A61K31/517A61K33/243
CPCA61K9/0073A61K31/337A61K31/517A61K31/5377A61K31/7048A61K33/24A61K47/02A61K33/00A61K9/0078A61K31/00A61P11/00A61P35/00A61K33/243A61K2300/00
Inventor 林信涌
Owner 林信涌
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products